	Phase II Trial of Opaganib Addition in Metastatic Castration-Resistant Prostate Cancer After Disease Progression on Abiraterone or Enzalutamide. Cancer Med Brown JT, Nazha B, Ferreira AC, Armeson K, Hill EG, Ogretmen B, Mehrotra S, Brisendine A, Magrath G, Plasse TF, Gourdin TS, Kucuk O, Lilly M. PMID: 41981710 [PubMed - indexed for MEDLINE]
	Soluble immune checkpoints as diagnostic biomarkers in bladder cancer. Biomark Res Andrzejczak A, Krajewski W, Jasku, Chorbi, Tomkiewicz A, Sarat K, Mroczek R, Ma, Szyde, Karabon L. PMID: 41981705 [PubMed - in process]
	The pulmonary artery hypertension and cancer: PULAHYCA PILOT study. Initial prostanoid therapy in cancer patients with pulmonary hypertension: results from an observational study. Cardiooncology Gregorietti V, López-Fernández T, Herrmann J, Costa D, Daniele AJ. PMID: 41981690 [PubMed - as supplied by publisher]
	Targeting MET in non-small cell lung cancer brain metastases: from molecular mechanism to precision therapy. J Transl Med Wang X, Chi Y, Mu F, Mao H, Yang C, Yang M. PMID: 41981677 [PubMed - as supplied by publisher]
	Lysosome-centered nanomedicine for cancer therapy: mechanisms, materials, and modalities. J Nanobiotechnology Xu R, Li N, Chen X, Zou M, Feng W, Zhou Z, Guo Z, Zhao X, Liu S, Cui L. PMID: 41981672 [PubMed - as supplied by publisher]
	Surgical approaches to esophageal cancer gastrointestinal reconstruction: a systematic review of jejunum, colon, and ileocolonic interposition with comparative outcome analysis. World J Surg Oncol Liu X, Dai J, Yin M, Zhang R, Song Y. PMID: 41981663 [PubMed - as supplied by publisher]
	Cellular plasticity and heterogeneity underlying therapy resistance in 3D cervical cancer models. Hereditas Olvera-Valencia M, Grijalva-Pérez A, Millan-Catalan O, Albino-Sánchez ME, Cháirez-Ramírez MH, Méndez-Martínez R, López-Urrutia E, Pérez-Plasencia C, García-Carrancá A. PMID: 41981662 [PubMed - as supplied by publisher]
	Comparison of overall survival across treatment modalities for oesophageal, gastroesophageal, and gastric cancer: protocol for a systematic review and network meta-analysis. Syst Rev Apostolidou-Kiouti F, Haidich AB, Mavridis D, Apostolaki AI, Tsavdaris D, Nikolakopoulou A. PMID: 41981647 [PubMed - as supplied by publisher]
	Advances in research on circadian rhythms and colorectal cancer. BMC Med Genomics Jia L, Zhu M, Wu X, Zheng W, Zhang Y, Xiao J. PMID: 41981628 [PubMed - as supplied by publisher]
	MTHFD1L in muscle invasive bladder cancer: a multi-cohort study on prognosis and therapeutic response. World J Surg Oncol Peng S, Liu Y, Huang P, Liu Q, Zhang L, Hsu CY, Zeng Y, Lu J, Zhao H, Cai C. PMID: 41981612 [PubMed - as supplied by publisher]
	CK7-positive hepatocellular carcinoma represents a distinct subtype: a retrospective cohort study. BMC Cancer Liu X, Li J, Yang C, Su Z, Xiang B. PMID: 41981525 [PubMed - as supplied by publisher]
	Real-world trends in diagnosis, treatment, and survival of non-small cell lung cancer in Vietnam. BMC Cancer Pham VH, Duong DC, Nguyen VB, Do HN, Nguyen KT, Nguyen TTM, Pham TH, Ngo VL, Nguyen VT, Ho MD, Truong KH, Ho BD, Nguyen VN. PMID: 41981524 [PubMed - as supplied by publisher]
	CBL combined with MDT mode in clinical teaching of liver cancer: a randomized controlled study. BMC Med Educ Zhang S, Li J, Deng C, Zheng S. PMID: 41981396 [PubMed - as supplied by publisher]
	Adverse Effects of Low Serum HDL-C Levels on Prognosis and Tumor Immune Microenvironment in Patients With Newly Diagnosed Chronic Lymphocytic Leukemia. Cancer Med Lv W, Liu S, Song J, Liang Z, Liao H, Huang Q, Zhu Z, Mo Z, Wang Y, Liang Y. PMID: 41981359 [PubMed - indexed for MEDLINE]
	Overweight and obesity increase breast cancer risk in postmenopausal women: a meta-analysis of 38 observational studies. Geroscience Del Console P, Catalano S, Gy. PMID: 41981355 [PubMed - as supplied by publisher]
	A differentiated thyroid carcinoma-specific graded prognostic assessment for brain metastases: derivation in a 10,306-patient cohort and external validation. J Neurooncol Salim HA, Agosto S, Qudah HA, Learned K, Zafereo M, Wang J, Hu MI, Msherghi A, Busaidy N, Ucisik FE, Hamidi S, Tawbi H, Eldaya RW, Li J, Wintermark M, Cabanillas ME. PMID: 41981321 [PubMed - indexed for MEDLINE]
	Longitudinal associations of cardiorespiratory fitness and physical activity with changes in cognitive function in breast cancer patients undergoing chemotherapy: a prospective matched-control study. Cancer Causes Control Xiao H, Warner E, Ryan J, Sabiston C, Ghazinour G, O'Rourke S, Moore D, Welsh T, Trinh L. PMID: 41981302 [PubMed - indexed for MEDLINE]
	CT imaging features as predictors of homologous recombination deficiency and prognosis in high-grade serous ovarian cancer. Abdom Radiol (NY) Kojo S, Takada A, Yokota H, Otsuka S, Matsuoka A, Nishikimi K, Tate S, Yoshida H, Sugawara H, Namba S, Horikoshi T, Nasu K, Uno T. PMID: 41981272 [PubMed - as supplied by publisher]
	Industrial point source emissions and incident breast and lung cancers: two case-control studies. Cancer Causes Control Boyle J, Nana-Sinkam P, McGuire KP, Fuemmeler BF. PMID: 41981156 [PubMed - indexed for MEDLINE]
	A 2026 update on myelodysplastic neoplasms: current state, challenges and future directions. Nat Rev Clin Oncol Bewersdorf JP, Mina A, Stahl M, Zeidan AM. PMID: 41981151 [PubMed - as supplied by publisher]

Articles 1 - 20 / 1926761

Page 1 of 96339



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy